Home/Filings/4/0000899243-20-034490
4//SEC Filing

Orford Keith 4

Accession 0000899243-20-034490

CIK 0001496671other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 5:00 PM ET

Size

4.9 KB

Accession

0000899243-20-034490

Insider Transaction Report

Form 4
Period: 2020-12-16
Orford Keith
SR. VP, CLINICAL DEVELOPMENT
Transactions
  • Sale

    Common Stock

    2020-12-16$6.00/sh2,447$14,68211,094 total
Footnotes (2)
  • [F1]Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan.
  • [F2]Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on each of June 10, 2020 and December 10, 2020.

Issuer

Calithera Biosciences, Inc.

CIK 0001496671

Entity typeother

Related Parties

1
  • filerCIK 0001670740

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 5:00 PM ET
Size
4.9 KB